Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial

Published:2021-07 Issue: Volume:37 Page:100978
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Feldman Peter R.^ORCID,Fiebig Klaus M.,Piwko Charles,Mints Boris M.^ORCID,Brown Dennis,Cahan Deborah J.,Guevara-Aguirre Jaime

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Hair and scalp disorders: medical, surgical, and cosmetic treatments, second edition;McMichael,2018

2. Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis;Matsumura;Science,2016

3. Psychological effects on androgenetic alopecia on women: comparisons with balding and female control subjects;Cash;J Am Acad Dermatol,1993

4. Microarray analysis of androgenetic and senescent alopecia: comparison of gene expression shows two distinct profiles;Karnik;J Dermatol Sci,2013

5. Incidence of female androgenetic alopecia (female pattern alopecia);Norwood;Dermatol Surg,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy;International Journal of Molecular Sciences;2024-07-11

2. Efluvio telógeno;Piel;2024-04

3. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis;Frontiers in Medicine;2023-01-23

4. Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium;Frontiers in Medicine;2022-08-04

5. Industry updates from the field of stem cell research and regenerative medicine in October 2021;Regenerative Medicine;2022-02